This product contains dry powder of mycelium obtained by submerged liquid fermentation of Cephalospovium sinensis Chen.sp.nov which is isolated from fresh Cordyceps. This product can improve the sinus rhythm, sinoatrial node, atrioventricular conduction function and cardiac function, and is indicated for a variety of arrhythmias, atrioventricular block, refractory slow arrhythmias, and conduction block.
Dosage and administration: Oral, 2 capsules/time, 3 times daily, or follow the medical advice.
Adverse reactions: uncertain.
Warnings and Precautions: Use with caution in pregnant.
Reference specification: WS3-B-2120-96
Approval No.: SFDA Approval No. Z53020150
Marketing Authorization Holder: Company Name: Kunming Sinoway Pharmaceutical Co.Ltd..